| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80b6d5d3fcc70716e7a92a47dc162b6d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 |
| filingDate |
2022-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c014de3fac2fceaff5a94f00302c8ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50ca12755eaf88d3888040874048f57b |
| publicationDate |
2022-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022150356-A1 |
| titleOfInvention |
Cancer treatment regimen using anti-parasitic compounds and gut microbiome modulating agents |
| abstract |
A composition and method of cancer treatment including a) administering to a patient a first anti-parasitic agent; b) administering to the patient a second anti-parasitic agent; and c) administering to the patient a gut microbiome modulating agent; wherein the first anti-parasitic agent and the second anti-parasitic agent are administered concurrently for a predetermined first period of time; and wherein the gut microbiome modulating agent is administered for a predetermined second period of time. |
| priorityDate |
2021-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |